Patent Assignment
Reel/Frame 059281/0037
Assignment of Assignor's Interest
Recorded: 2022-03-16
Pages: 6
Assignor
RUEGG, CURTIS L.
Executed: 2018-05-04
Assignee
REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD, NEWARK, CALIFORNIA, 94560
Covered Property
(1)
Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect
Application:
17/472,525 →
Publication:
US 2022/0062400
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Employee Proprietary Information and Inventions Agreement
Mar 17, 2022
From: WAUGH, JACOB
To: ESSENTIA BIOSYSTEMS, INC.
Reel/Frame 059435/0362 →
Change of Name
Mar 17, 2022
From: ESSENTIA BIOSYSTEMS, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 059435/0371 →
Security Interest
Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0663 →
Release of Security Interest
Feb 7, 2025
From: ATHYRIUM BUFFALO LP
To: REVANCE THERAPEUTICS, INC
Reel/Frame 070153/0630 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; BELLUS MEDICAL, LLC; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0736 →
Security Interest
Feb 17, 2025
From: REVANCE THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 070239/0739 →